NEW YORK (BUSINESS WIRE) Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the formation of its inaugural Clinical Development Advisory Board. The board is composed of four distinguished physicians and scientists who wil.
The companies aiming to beat cancer serve up the highlights in the June quarter proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Renowned Biopharma Leaders Join Newly Established Kallyope Clinical Development Advisory Board - read this article along with other careers information, tips and advice on BioSpace
Arovella Therapeutics Ltd (ASX:ALA) will appoint Dr Elizabeth Stoner as interim chairperson following the planned departure of Paul Hopper from his role as.